TrialAnnals of oncology : official journal of the European Society for Medical Oncology2009

Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer.

B Burtness et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.